Impact of Enzyme Replacement Therapy on Linear Growth in Korean Patients with Mucopolysaccharidosis Type II (Hunter Syndrome)

Hunter syndrome (or mucopolysaccharidosis type II [MPS II]) arises because of a deficiency in the lysosomal enzyme iduronate-2-sulfatase. Short stature is a prominent and consistent feature in MPS II. Enzyme replacement therapy (ERT) with idursulfase (Elaprase®) or idursulfase beta (Hunterase®) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sung Yoon, Huh, Rimm, Chang, Mi Sun, Lee, Jieun, Kwun, Younghee, Maeng, Se Hyun, Kim, Su Jin, Sohn, Young Bae, Park, Sung Won, Kwon, Eun-Kyung, Han, Sun Ju, Jung, Jooyoun, Jin, Dong-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924006/
https://www.ncbi.nlm.nih.gov/pubmed/24550654
http://dx.doi.org/10.3346/jkms.2014.29.2.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924006/
https://www.ncbi.nlm.nih.gov/pubmed/24550654
http://dx.doi.org/10.3346/jkms.2014.29.2.254

Ejemplares similares